Imatinib mesylate in the treatment of newly diagnosed or refractory/resistant c-KIT positive acute myeloid leukemia. Results of an italian multicentric phase II study.
暂无分享,去创建一个
R. Fanin | M. Baccarani | P. Piccaluga | M. Rondoni | S. Paolini | G. Martinelli | G. Saglio | D. Russo | M. Pirrotta | G. Visani | D. Alberti | F. Lauria | A. Candoni | M. Malagola | E. Messa | M. Arpinati | F. Rancati | V. Vinaccia